
Marksans Pharma Limited has informed the Exchange regarding a press release dated May 26, 2026, titled "Marksans Pharma Marksans Pharma Hits Historic Triple: Highest Revenue, EBITDA & PAT ₹3,000 Cr Net Income Guidance Delivered".
Filed with NSE · · 5 pages · English

Marksans Pharma Limited has informed the Exchange regarding a press release dated May 26, 2026, titled "Marksans Pharma Marksans Pharma Hits Historic Triple: Highest Revenue, EBITDA & PAT ₹3,000 Cr Net Income Guidance Delivered".
Marksans Pharma Limited on 6ix
Follow Marksans Pharma into a list and get an email when it puts out news.
Follow Marksans Pharma